ScholarIQanswers from OpenAlex & ORCID
Robert J. Mayer
ResearcherPublications, citations & collaboration network
Robert J. Mayer is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Robert J. Mayer have?
ScholarIQindexed works
Robert J. Mayer has 626 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Robert J. Mayer have?
ScholarIQcitation count
Robert J. Mayer has 51,235 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Robert J. Mayer?
ScholarIQh-index
Robert J. Mayer has an h-index of 110 in OpenAlex.
What is the i10-index of Robert J. Mayer?
ScholarIQi10-index
Robert J. Mayer has an i10-index of 316 in OpenAlex.
What is the ORCID of Robert J. Mayer?
ScholarIQorcid
The ORCID for Robert J. Mayer is on the source record.
What is the OpenAlex record for Robert J. Mayer?
ScholarIQopenalex
The OpenAlex for Robert J. Mayer is on the source record.
What are the most-cited papers on Robert J. Mayer?
ScholarIQmost cited works
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Robert J. Mayer, Roger B. Davis, Charles A. Schiffer, Deborah Berg, Bayard L. Powell, Philip Schulman, George Omura, Joseph O. Moore, O. Ross McIntyre, E Frei
Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781
Joel E. Tepper, Mark J. Krasna, Donna Niedzwiecki, Donna Hollis, Carolyn E. Reed, Richard M. Goldberg, Krystyna Kiel, Christopher G. Willett, David J. Sugarbaker, Robert J. Mayer
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer
Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz, Federico Innocenti, Briant Fruth, Jeffrey A. Meyerhardt, Deborah Schrag, Claire Greene, Bert H. O’Neil, James N. Atkins, Scott Berry, Blasé N. Polite, Eileen M. O’Reilly, Richard M. Goldberg, Howard S. Höchster, Richard L. Schilsky, Monica M. Bertagnolli, Anthony B. El-Khoueiry, Peter J. Watson, Al B. Benson, Daniel Mulkerin, Robert J. Mayer, Charles D. Blanke
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
Hedy L. Kindler, Donna Niedzwiecki, Donna Hollis, Susan Sutherland, Deborah Schrag, Herbert I. Hurwitz, Federico Innocenti, Mary F. Mulcahy, Eileen M. O’Reilly, Timothy F. Wozniak, Joel Picus, Pankaj Bhargava, Robert J. Mayer, Richard L. Schilsky, Richard M. Goldberg
Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803
Jeffrey A. Meyerhardt, Denise Heseltine, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, James P. Thomas, Heidi Nelson, Renaud Whittom, Alexander Hantel, Richard L. Schilsky, Charles S. Fuchs